Evidence mapPaperPMID 40855489Full record

ArticleJournal of nanobiotechnology2025

Lithium-doped calcium silicate scaffolds-activated M2-polarized macrophage-derived miR-145-5p-riched extracellular vesicles to enhance osteoimmunomodulation for accelerating bone regeneration.

Ting-You Kuo, Tsung-Li Lin, Yen-Hong Lin, Cheng-Yu Chen, Der-Yang Cho, Yi-Wen Chen, Ming-You Shie

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ting-You Kuo *Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan.
Tsung-Li Lin *Department of Sports Medicine, College of Health Care, China Medical University, Taichung, 406040, Taiwan.
Yen-Hong LinDepartment of Biomedical Engineering, China Medical University, Taichung, 406040, Taiwan.
Cheng-Yu ChenResearch & Development Center for x-Dimensional Extracellular Vesicles, China Medical University Hospital, Taichung, 404332, Taiwan.
Der-Yang ChoGraduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan.
Yi-Wen ChenGraduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan.
Ming-You ShieDepartment of Biomedical Engineering, China Medical University, Taichung, 406040, Taiwan. eric@mail.cmu.edu.tw.

Funding

China Medical University Hospital DMR-114-010National Science and Technology Council NSTC 112-2628-E-039-001-MY3National Science and Technology Council NSTC 113-2314-B-039-053National Science and Technology Council NSTC 113-2811-E-039-001
6 · The paper itself

Abstract

Bone healing is intricately associated with dynamic macrophage polarization. Modulating macrophages toward the M2 phenotype has emerged as a promising strategy in bone tissue engineering. Calcium silicate, known for its superior osteoconductivity, is widely used as a bone substitute and is particularly effective in promoting bone tissue regeneration when incorporated with bioactive ions. Recent studies have highlighted lithium's immunomodulatory effects, with extracellular vesicles (EVs) identified as potential mediators of these actions. Although M2 macrophage-derived EVs (M2-EVs) have been shown to promote bone regeneration, the underlying mechanisms through which biomaterial-stimulated M2-EVs regulate bone regeneration remain unclear. This study investigated the immunomodulatory effects of lithium-doped calcium silicate (LiCS) scaffolds on macrophages and associated inflammatory cytokine profiles. Notably, miR-145-5p was significantly upregulated in both LiCS-stimulated macrophages and their secreted EVs, suggesting a potential regulatory role. Characterization of these miR-145-5p-enriched EVs revealed enhanced anti-inflammatory responses, stimulation of angiogenesis, and upregulation of osteogenic markers in relation to M1 macrophages, mesenchymal stem cells, and endothelial cells. These findings elucidate the molecular basis of LiCS-stimulated M2-EV-regulated bone regeneration via miR-145-5p, providing new insights into developing immunomodulatory biomaterials in regenerative medicine.

Indexed as

Bone RegenerationCalcium CompoundsExtracellular VesiclesLithiumMacrophagesMicroRNAsSilicatesTissue ScaffoldsAnimalsHumansImmunomodulationMesenchymal Stem CellsMiceOsteogenesisRAW 264.7 CellsCalcium Compoundscalcium silicateLithiumMicroRNAsSilicatesImmunomodulationLithium-doped calcium silicate scaffoldsM2 macrophage-derived EVsMacrophage polarizationRegenerative medicine

Identifiers

PMID40855489
PMCPMC12376704

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.